Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03414060Not ApplicableCompleted

Feasibility of the Menstrual Cup for VVF

Role: lead

NCT07488091Not ApplicableRecruiting

Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana

Role: lead

NCT06985199Not ApplicableEnrolling By Invitation

Culturally-adapted Mobile Health Intervention for Hypertension Care

Role: collaborator

NCT06632288Completed

Family Participation in Ghana Hospital Care

Role: collaborator

NCT04949165Not ApplicableCompleted

Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study

Role: collaborator

NCT05837559Not ApplicableUnknown

Traditional WHO Partograph and Korle-Bu Modified WHO Partograph for Uncomplicated Labour

Role: lead

NCT03062228Completed

KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section

Role: collaborator

NCT03070795Not ApplicableUnknown

Outcomes of Early Versus Delayed Oral Feeding After Cesarean Section in Korle-bu Teaching Hospital

Role: lead

NCT02593734Phase 4Completed

Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

Role: lead

NCT00406146Phase 3Unknown

Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children

Role: lead

All 10 trials loaded